These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 24902359)

  • 21. Lack of ERG-antibody in Benign Mimickers of Prostate Cancer.
    Bachurska SY; Staykov DG; Ivanov GP; Belovezhdov VT
    Folia Med (Plovdiv); 2016 Mar; 58(1):48-53. PubMed ID: 27383878
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Minimal adenocarcinoma in prostate needle biopsy tissue.
    Thorson P; Humphrey PA
    Am J Clin Pathol; 2000 Dec; 114(6):896-909. PubMed ID: 11338479
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of prostate needle biopsies in a population-based screening study: the impact of borderline lesions.
    Hoedemaeker RF; Kranse R; Rietbergen JB; Kruger AE; Schröder FH; van der Kwast TH
    Cancer; 1999 Jan; 85(1):145-52. PubMed ID: 9921986
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Partial atrophy in prostate needle biopsies: a detailed analysis of its morphology, immunophenotype, and cellular kinetics.
    Przybycin CG; Kunju LP; Wu AJ; Shah RB
    Am J Surg Pathol; 2008 Jan; 32(1):58-64. PubMed ID: 18162771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The focus of "atypical glands, suspicious for malignancy" in prostatic needle biopsy specimens: incidence, histologic features, and clinical follow-up of cases diagnosed in a community practice.
    Cheville JC; Reznicek MJ; Bostwick DG
    Am J Clin Pathol; 1997 Dec; 108(6):633-40. PubMed ID: 9384444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Partial atrophy on prostate needle biopsy cores: a morphologic and immunohistochemical study.
    Wang W; Sun X; Epstein JI
    Am J Surg Pathol; 2008 Jun; 32(6):851-7. PubMed ID: 18408595
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of immunohistochemistry in routine workup of prostate needle biopsies: a tertiary academic institution experience.
    Watson K; Wang C; Yilmaz A; Bismar TA; Trpkov K
    Arch Pathol Lab Med; 2013 Apr; 137(4):541-5. PubMed ID: 23273390
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Benign mimickers of the prostate cancer. Diagnostic challenges].
    Compérat E; Varinot J; Srigley JR
    Ann Pathol; 2013 Aug; 33(4):237-46. PubMed ID: 23954116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibody-based detection of ERG rearrangements in prostate core biopsies, including diagnostically challenging cases: ERG staining in prostate core biopsies.
    Tomlins SA; Palanisamy N; Siddiqui J; Chinnaiyan AM; Kunju LP
    Arch Pathol Lab Med; 2012 Aug; 136(8):935-46. PubMed ID: 22849743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Small glandular proliferations on needle biopsies: most common benign mimickers of prostatic adenocarcinoma sent in for expert second opinion.
    Herawi M; Parwani AV; Irie J; Epstein JI
    Am J Surg Pathol; 2005 Jul; 29(7):874-80. PubMed ID: 15958851
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Histopathological features of prostate cancer].
    Kozuka Y; Imai H; Yamanaka M; Kozuka M; Uchida K; Shiraishi T
    Nihon Rinsho; 2005 Feb; 63(2):231-6. PubMed ID: 15714971
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extent of prostatic atrophy in needle biopsies and serum PSA levels: is there an association?
    Billis A; Meirelles LR; Magna LA; Baracat J; Prando A; Ferreira U
    Urology; 2007 May; 69(5):927-30. PubMed ID: 17482936
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitation of conventional histologic parameters and biologic factors in prostatic needle biopsy are useful to distinguish paramalignant from malignant disease.
    Silva LC; Saldiva PH; Ellinger F; Filho BL; Capelozzi VL; Antonangelo L
    Pathol Res Pract; 2004; 200(9):599-608. PubMed ID: 15497772
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Morphological transition of proliferative inflammatory atrophy to high-grade intraepithelial neoplasia and cancer in human prostate.
    Wang W; Bergh A; Damber JE
    Prostate; 2009 Sep; 69(13):1378-86. PubMed ID: 19507201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic Value of ERG in Prostate Needle Biopsies Containing Minute Cancer Foci.
    Bachurska SY; Staykov DG; Bakardzhiev IV; Antonov PA; Belovezhdov VT
    Folia Med (Plovdiv); 2017 Mar; 59(1):84-90. PubMed ID: 28384107
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adenosis of the prostate. Histologic features in needle biopsy specimens.
    Gaudin PB; Epstein JI
    Am J Surg Pathol; 1995 Jul; 19(7):737-47. PubMed ID: 7793471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of prostate specific membrane antigen (PSMA) in prostatic adenocarcinoma and prostatic intraepithelial neoplasia.
    Marchal C; Redondo M; Padilla M; Caballero J; Rodrigo I; García J; Quian J; Boswick DG
    Histol Histopathol; 2004 Jul; 19(3):715-8. PubMed ID: 15168332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Benign mimickers of prostatic adenocarcinoma: diagnostic features and differential diagnosis].
    Cheng L; Huang W; Li Y; Wang L
    Zhonghua Bing Li Xue Za Zhi; 2014 Jan; 43(1):52-8. PubMed ID: 24713255
    [No Abstract]   [Full Text] [Related]  

  • 39. Use of interphase fluorescence in situ hybridization in prostate needle biopsy specimens with isolated high-grade prostatic intraepithelial neoplasia as a predictor of prostate adenocarcinoma on follow-up biopsy.
    Bastacky S; Cieply K; Sherer C; Dhir R; Epstein JI
    Hum Pathol; 2004 Mar; 35(3):281-9. PubMed ID: 15017583
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cells in various benign and malignant conditions of the human prostate express different antigenic phenotypes.
    Turhan OI; Aydin NE; Sariyüce O; Ozkan S
    Int Urol Nephrol; 1998; 30(6):731-44. PubMed ID: 10195869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.